TTY Biopharm Company Limited (TPEX:4105)
Taiwan
· Delayed Price · Currency is TWD 73.90
-0.60 (-0.81%)
Apr 24, 2025, 1:30 PM CST
TTY Biopharm Company Revenue
In the year 2024, TTY Biopharm Company had annual revenue of 5.89B TWD with 7.05% growth. TTY Biopharm Company had revenue of 1.71B in the quarter ending December 31, 2024, with 4.10% growth.
Revenue
5.89B
Revenue Growth
+7.05%
P/S Ratio
3.12
Revenue / Employee
17.23M
Employees
342
Market Cap
18.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.89B | 388.31M | 7.05% |
| Dec 31, 2023 | 5.51B | 443.94M | 8.77% |
| Dec 31, 2022 | 5.06B | 526.00M | 11.60% |
| Dec 31, 2021 | 4.54B | 313.77M | 7.43% |
| Dec 31, 2020 | 4.22B | -244.47M | -5.47% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.82B |
| Lumosa Therapeutics | 39.15M |